Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Schenone

Showing results (21-30 of 173) with videos related to

Pageof 18
Sort By:
Current Medicinal Chemistry|January 17, 2020
Insights into RNA-dependent RNA Polymerase Inhibitors as Antiinfluenza Virus AgentsIlaria Giacchello, Francesca Musumeci, Ilaria D'Agostino, et al.
Molecules (Basel, Switzerland)|December 10, 2021
Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of NeuroblastomaFrancesca Musumeci, Annarita Cianciusi, Ilaria D'Agostino, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 2008
N-(thiazol-2-yl)-2-thiophene carboxamide derivatives as Abl inhibitors identified by a pharmacophore-based database screening of commercially available compoundsFabrizio Manetti, Federico Falchi, Emmanuele Crespan, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Probing In Silico the Benzimidazole Privileged Scaffold for the Development of Drug-like Anti-RSV AgentsElena Cichero, Alessio Calautti, Valeria Francesconi, et al.
Bioorganic & Medicinal Chemistry|December 27, 2005
Synthesis of new piperazine-pyridazinone derivatives and their binding affinity toward alpha1-, alpha2-adrenergic and 5-HT1A serotoninergic receptorsLaura Betti, Marco Zanelli, Gino Giannaccini, et al.
International Journal of Molecular Sciences|February 10, 2024
Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma TreatmentDavide Frumento, Giancarlo Grossi, Marta Falesiedi, et al.
Experimental Cell Research|August 17, 2014
Src inhibition potentiates antitumoral effect of paclitaxel by blocking tumor-induced angiogenesisSimona Delle Monache, Patrizia Sanità, Alessia Calgani, et al.
Current Medicinal Chemistry|March 8, 2017
Pyrrolo[2,3-d]Pyrimidines as Kinase InhibitorsFrancesca Musumeci, Monica Sanna, Giancarlo Grossi, et al.
Current Opinion in Pharmacology|July 5, 2014
Protein-protein interactions and human cellular cofactors as new targets for HIV therapyCristina Tintori, Annalaura Brai, Anna Lucia Fallacara, et al.
Journal of Computer-Aided Molecular Design|August 21, 2003
Exploring the molecular basis of selectivity in A1 adenosine receptors agonists: a case studyFabrizio Giordanetto, Paola Fossa, Giulia Menozzi, et al.
Pageof 18

Showing results (21-30 of 173) with videos related to

Sort By:
Pageof 18
Current Medicinal Chemistry|January 17, 2020
Insights into RNA-dependent RNA Polymerase Inhibitors as Antiinfluenza Virus AgentsIlaria Giacchello, Francesca Musumeci, Ilaria D'Agostino, et al.
Molecules (Basel, Switzerland)|December 10, 2021
Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of NeuroblastomaFrancesca Musumeci, Annarita Cianciusi, Ilaria D'Agostino, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 2008
N-(thiazol-2-yl)-2-thiophene carboxamide derivatives as Abl inhibitors identified by a pharmacophore-based database screening of commercially available compoundsFabrizio Manetti, Federico Falchi, Emmanuele Crespan, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Probing In Silico the Benzimidazole Privileged Scaffold for the Development of Drug-like Anti-RSV AgentsElena Cichero, Alessio Calautti, Valeria Francesconi, et al.
Bioorganic & Medicinal Chemistry|December 27, 2005
Synthesis of new piperazine-pyridazinone derivatives and their binding affinity toward alpha1-, alpha2-adrenergic and 5-HT1A serotoninergic receptorsLaura Betti, Marco Zanelli, Gino Giannaccini, et al.
International Journal of Molecular Sciences|February 10, 2024
Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma TreatmentDavide Frumento, Giancarlo Grossi, Marta Falesiedi, et al.
Experimental Cell Research|August 17, 2014
Src inhibition potentiates antitumoral effect of paclitaxel by blocking tumor-induced angiogenesisSimona Delle Monache, Patrizia Sanità, Alessia Calgani, et al.
Current Medicinal Chemistry|March 8, 2017
Pyrrolo[2,3-d]Pyrimidines as Kinase InhibitorsFrancesca Musumeci, Monica Sanna, Giancarlo Grossi, et al.
Current Opinion in Pharmacology|July 5, 2014
Protein-protein interactions and human cellular cofactors as new targets for HIV therapyCristina Tintori, Annalaura Brai, Anna Lucia Fallacara, et al.
Journal of Computer-Aided Molecular Design|August 21, 2003
Exploring the molecular basis of selectivity in A1 adenosine receptors agonists: a case studyFabrizio Giordanetto, Paola Fossa, Giulia Menozzi, et al.
Pageof 18